Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana

NACompletedINTERVENTIONAL
Enrollment

5,861

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

January 31, 2023

Conditions
Malaria Asymptomatic Parasitaemia
Interventions
OTHER

Mass testing using RDTs

To determined the prevalence of asymptomatic malaria parasitaemia. In arm 1 all participants will be tested six times over the study period while in arm 2 the participants will be only be tested at baseline and evaluation.

DRUG

Treatment for all cases confirmed positive malaria cases with ACTs

During each mass testing, all confirmed positive cases are treated in both arms.

OTHER

Determination of Hb

Hb of all children in the subgroup study are measured using a haemocure photometer.

OTHER

Household survey

Determine the prevalence of febrile illnesses among children in the subgroup study

OTHER

Community-base management of malaria

Between interventions, participant who become febrile are tested and treated if confirmed positive for malaria by CHWs

Trial Locations (1)

+233

Noguchi Memorial Institute for Medical Research, Accra

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ghana National Malaria Control Programme

UNKNOWN

collaborator

Communities

UNKNOWN

lead

Noguchi Memorial Institute for Medical Research

OTHER